Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gunn

Showing results (131-140 of 216) with videos related to

Pageof 22
Sort By:
Brain : a Journal of Neurology|July 27, 2015
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's diseaseFlavia Niccolini, Thomas Foltynie, Tiago Reis Marques, et al.
Brain : a Journal of Neurology|May 7, 2019
Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal systemAntonio Martín-Bastida, Nicholas P Lao-Kaim, Andreas Antonios Roussakis, et al.
Neurology|September 10, 2003
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophyA Gerhard, R B Banati, G B Goerres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2015
Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer DiseaseChristine A Parker, Eugenii A Rabiner, Roger N Gunn, et al.
EJNMMI Research|June 28, 2015
An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M 1) positive allosteric modulator in the living human brain using positron emission tomographyKhanum Ridler, Vincent Cunningham, Mickael Huiban, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [<sup>11</sup>C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.
Brain : a Journal of Neurology|October 21, 2017
Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosisGourab Datta, Alessandro Colasanti, Eugenii A Rabiner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 23, 2018
PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyFlavia Niccolini, Niccolo E Mencacci, Tayyabah Yousaf, et al.
Nuclear Medicine and Biology|August 17, 2011
Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10AChristophe Plisson, Cristian Salinas, David Weinzimmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2020
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's DiseaseHeather Wilson, Gennaro Pagano, Edoardo Rosario de Natale, et al.
Pageof 22

Showing results (131-140 of 216) with videos related to

Sort By:
Pageof 22
Brain : a Journal of Neurology|July 27, 2015
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's diseaseFlavia Niccolini, Thomas Foltynie, Tiago Reis Marques, et al.
Brain : a Journal of Neurology|May 7, 2019
Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal systemAntonio Martín-Bastida, Nicholas P Lao-Kaim, Andreas Antonios Roussakis, et al.
Neurology|September 10, 2003
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophyA Gerhard, R B Banati, G B Goerres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2015
Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer DiseaseChristine A Parker, Eugenii A Rabiner, Roger N Gunn, et al.
EJNMMI Research|June 28, 2015
An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M 1) positive allosteric modulator in the living human brain using positron emission tomographyKhanum Ridler, Vincent Cunningham, Mickael Huiban, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [<sup>11</sup>C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.
Brain : a Journal of Neurology|October 21, 2017
Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosisGourab Datta, Alessandro Colasanti, Eugenii A Rabiner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 23, 2018
PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyFlavia Niccolini, Niccolo E Mencacci, Tayyabah Yousaf, et al.
Nuclear Medicine and Biology|August 17, 2011
Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10AChristophe Plisson, Cristian Salinas, David Weinzimmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2020
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's DiseaseHeather Wilson, Gennaro Pagano, Edoardo Rosario de Natale, et al.
Pageof 22